Gaboxadol is a research compound that acts as an agonist at GABAA receptors. It was investigated for potential applications in sleep disorders and has been studied for conditions such as Angelman syndrome, but it was never marketed.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 64603-91-4
(RS)-pentobarbital
pharmaceutical raw material
Chlorprothixene hydrochloride
pharmaceutical raw material
1',4-Dihydroxy Midazolam
pharmaceutical raw material
Lanthanum carbonate octahydrate
pharmaceutical raw material
Butoconazole nitrate
pharmaceutical raw material
4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one
ZXRVKCBLGJOCEE-UHFFFAOYSA-N
C1CNCC2=C1C(=O)NO2